"covid-19" prototype clinical trials.

Active Other Transaction Agreement Awarded Last action

Contract number
W911QY2090007
Awardee
Awarding agency
Obligated
$78,227,061

Award facts

Contract value 100% obligated
  • $78,227,060.68 Current, with exercised options
  • $78,461,505.99 Potential, with all options
Completion date 95% complete
Current and potential, with all options
Funding agency
Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
NAICS code
Not on record
Competition
Competed Broad Agency Announcement
Pricing
Other
Place of performance
Hinckley, OH 44233, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00020 · Covid-19 phase i, II, III clinical trials in support of covid-10 vaccines and therapeutics, and botulinum phase II clinical trial. $65,555
Supplemental Agreement for work within scope P00019 $0
Other Administrative Action P00018 $0
Change Order P00017 $1,302,383
Supplemental Agreement for work within scope P00016 $0
Supplemental Agreement for work within scope P00015 · Covid-19 phase i, II, III clinical trials in support of covid 19 vaccines and therapeutics. -$57,324,404
Supplemental Agreement for work within scope P00014 $0
Supplemental Agreement for work within scope P00013 · Covid - 19 clinical trials $0
Supplemental Agreement for work within scope P00012 · Phase i clinical trial $0
Supplemental Agreement for work within scope P00011 · "covid-19" prototype OTA for clinical trials. Modification to add a study and align funding and agreement value. $0
Other Administrative Action P00010 · "covid-19" no cost extension for clins 0001-0006, and 0008 and 0009. $0
Supplemental Agreement for work within scope P00009 · "covid-19" revisions to clins 0001 and 0009. $0
Supplemental Agreement for work within scope P00008 · "covid-19" additional ology phase II. $0
Funding Only Action P00007 · "covid-19" funding deobligation -$79,232,000
Other Administrative Action P00006 · "covid-19" correct delivery dates. $0
Supplemental Agreement for work within scope P00004 · "covid-19" realignment of clin values. No change to cost. $0
Supplemental Agreement for work within scope P00003 · "covid-19" additional clinical trials, phase III $168,510,974
Funding Only Action P00002 $24,074,552
Funding Only Action P00001 · "covid-19" funding modification $16,030,000
Original award $4,800,000
Show all 20

About this award

The Department of Defense Joint PEO Chemical and Biological Defense awarded an Other Transaction Agreement to Icon Government And Public Health Solutions, Inc. valued at $78.5 million on April 28, 2020, for COVID-19 prototype clinical trials. This OTA sits outside the FAR and operates under the authority delegated to the Joint PEO for prototype and R&D acquisitions.

The agreement covers Phase I, II, and III clinical trials in support of COVID-19 vaccines and therapeutics development, as well as a Phase II clinical trial for botulinum. Work is performed in Hinckley, Ohio. The ultimate completion date is February 28, 2027. Icon Government And Public Health Solutions, Inc. is a foreign-owned, for-profit clinical research services provider based in Blue Bell, Pennsylvania, specializing in end-to-end clinical trial planning, execution, and support across infectious disease and medical countermeasure development.

Quick answers

Who was awarded contract W911QY2090007?

W911QY2090007 was awarded to Icon Government And Public Health Solutions, Inc. by ACC Aberdeen Proving Ground (Army Contracting Command) on April 28, 2020.

How much is contract W911QY2090007 worth?

The government has obligated $78,227,061 on W911QY2090007. Its potential value, with all options, is $78,461,506.

Which agency awarded contract W911QY2090007?

ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911QY2090007, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).

Was contract W911QY2090007 competed?

The extent of competition for W911QY2090007 was competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award